Dendrimer as a carrier for ocular drug delivery

Journal Title: Journal of Drug Discovery and Therapeutics - Year 2014, Vol 2, Issue 8

Abstract

The foremost challenges face by today’s researcher is ocular drug delivery. Delivery of drug to the targeted ocular tissue is restricted by various ocular barriers. To conquer the ocular drug delivery barriers and get better ocular bioavailability, different conventional and novel drug delivery agents have been used. Dendrimer act as a drug delivery agent for promising, safe and selective drug delivery option. It’s extremely high selective nature for target the desired amount of drug to the tissue is most essential property and holds a promising future for the treatment of various ophthalmic diseases. Dendrimer shows physiochemical properties like pH, osmolality, and viscosity etc that are more compatible with ocular dosage form to formulate different formulations for ocular diseases. The important advantages of dendrimer in ocular drug delivery are persistence in corneal residence time, which can improve the bioavailability of drug, and introduce in the form of eye drops. Dendrimers help in achieving increased bioavailability, sustained, controlled as well as targeted release of drug.

Authors and Affiliations

Tariq Baig*| Rameshwaram Institute of Technology & Managaement, Lucknow, Uttar Pradesh, India, Hammad Sheikh| Rameshwaram Institute of Technology & Managaement, Lucknow, Uttar Pradesh, India, Ankur Srivastava| Rameshwaram Institute of Technology & Managaement, Lucknow, Uttar Pradesh, India, Pushpendra K. Tripathi| Rameshwaram Institute of Technology & Managaement, Lucknow, Uttar Pradesh, India

Keywords

Related Articles

FORMULATION AND EVALUATION OF CONTROLLED RELEASE TABLETS OF MIGLITOL USING HYDROPHOBIC POLYMERS

In the present study, miglitol 25 mg controlled release matrices were prepared by direct compression and in vitro drug dissolution studies were performed to find out the drug release rate and patterns. Hydroxypropyl me...

EVALUATION OF PKD2 GENE (G/C) POLYMORPHISM IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE AMONG SOUTH INDIANS (MADURAI).

Polycystic kidney disease (PKD) is the leading causes of end-stage renal failure (ESRD) and a common indication of dialysis / renal transplantation. Autosomal dominant polycystic kidney disease (ADPKD) and autosomal rece...

NOVEL DRUG DELIVERY SYSTEM-NANOEMULSIONS: A RECENT REVIEW

Nanoemulsions are the emulsions of O/W type, having the size range of several microns. Nanoemulsions are clear, thermodynamically stable, isotropic liquid mixtures of oil, water, surfactant and co-surfactant. They are pr...

Transdermal drug delivery system: - a review on transdermal patch

The main advantage of Transdermal drug delivery system is to bypass the first pass metabolism, avertance of the risk and annoyance of intravenous therapy and of the varied conditions of absorption, like pH changes, gastr...

NATURAL SOURCE WITH POWER FOR TREATMENT OF CANCER: A RECENT REVIEW

Cancer is a major public health burden in both developed and developing countries. Studies have estimated that genetic factors cause only 5–10% of all human cancers, while the remaining percentage is caused by lifestyle....

Download PDF file
  • EP ID EP1510
  • DOI -
  • Views 416
  • Downloads 23

How To Cite

Tariq Baig*, Hammad Sheikh, Ankur Srivastava, Pushpendra K. Tripathi (2014). Dendrimer as a carrier for ocular drug delivery. Journal of Drug Discovery and Therapeutics, 2(8), 18-25. https://europub.co.uk/articles/-A-1510